Shibata Y - Search Results

1

Effect of etodolac on type-II collagen-induced arthritis in mice.

Inoue K, Motonaga A, Suzuka H, Yoshifusa H, Fujisawa H, Nishimura T, Inoue Y, Ueda F, Shibata Y, Kimura K. Inoue K, et al. Among authors: shibata y. Agents Actions. 1993 Jul;39(3-4):187-94. doi: 10.1007/BF01998973. Agents Actions. 1993. PMID: 8304247

2

Mechanism of anti-inflammatory action of etodolac.

Inoue K, Motonaga A, Nishimura T, Yokota M, Miki N, Fujisawa H, Ueda F, Shibata Y, Kimura K. Inoue K, et al. Among authors: shibata y. Arzneimittelforschung. 1991 Mar;41(3):235-9. Arzneimittelforschung. 1991. PMID: 1714278

3

Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions.

Yoshida-Suzuka H, Nakamura Y, Shibata Y, Kimura K. Yoshida-Suzuka H, et al. Among authors: shibata y. Agents Actions. 1991 Jul;33(3-4):310-3. doi: 10.1007/BF01986578. Agents Actions. 1991. PMID: 1835269

4

Effect of anti-inflammatory agent etodolac on antigen-induced contractions of the trachea and lung parenchyma of guinea pigs.

Inoue K, Hamada K, Ueda F, Shibata Y, Kimura K. Inoue K, et al. Among authors: shibata y. Prostaglandins Leukot Essent Fatty Acids. 1994 Dec;51(6):451-5. doi: 10.1016/0952-3278(94)90064-7. Prostaglandins Leukot Essent Fatty Acids. 1994. PMID: 7708811

5

Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.

Inoue K, Fujisawa H, Sasaki Y, Nishimura T, Nishimura I, Inoue Y, Yokota M, Masuda T, Ueda F, Shibata Y, et al. Inoue K, et al. Among authors: shibata y. Arzneimittelforschung. 1991 Mar;41(3):228-35. Arzneimittelforschung. 1991. PMID: 1651085

6

Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.

Suzuka H, Yoshifusa H, Nakamura Y, Miyawaki S, Shibata Y. Suzuka H, et al. Among authors: shibata y. Autoimmunity. 1993;14(4):275-82. doi: 10.3109/08916939309079229. Autoimmunity. 1993. PMID: 8347770

7

Antiinflammatory properties of the new antirheumatic agent 4-acetylaminophenylacetic acid.

Fujisawa H, Nishimura T, Inoue Y, Ogaya S, Shibata Y, Nakagawa Y, Sato S, Kimura K. Fujisawa H, et al. Among authors: shibata y. Arzneimittelforschung. 1990 Jun;40(6):693-7. Arzneimittelforschung. 1990. PMID: 2168705

8

Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus.

Suzuka H, Fujiwara H, Tanaka M, Yoshifusa H, Nakamura Y, Shibata Y. Suzuka H, et al. Among authors: shibata y. J Cardiovasc Pharmacol. 1995 Jan;25(1):9-13. doi: 10.1097/00005344-199501000-00003. J Cardiovasc Pharmacol. 1995. PMID: 7723359

9

A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice.

Miyawaki S, Nakamura Y, Suzuka H, Koba M, Yasumizu R, Ikehara S, Shibata Y. Miyawaki S, et al. Among authors: shibata y. Eur J Immunol. 1994 Feb;24(2):429-34. doi: 10.1002/eji.1830240224. Eur J Immunol. 1994. PMID: 8299692

10

Effects of chronic oral administration of nifedipine and diltiazem on occlusive thrombus of small coronary arteries in (NZW x BXSB)F1 male mice.

Tanaka M, Fujiwara H, Shibata Y, Kida M, Suzuka H, Kimura K, Kawai C. Tanaka M, et al. Among authors: shibata y. Cardiovasc Res. 1992 Jun;26(6):586-92. doi: 10.1093/cvr/26.6.586. Cardiovasc Res. 1992. PMID: 1451138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,705 results

Search Page